Recent Product/PR stories

SpaceX Wants To Turn AI Compute Into A $500B Business Next Year – And Elon Musk Says NASA’s Annual Budget Is No Match

Stocktwits News74 · bullish$SPCX

Novo Nordisk reports liver improvements with Wegovy in some patients

Seeking Alpha64 · neutral$NVO

AbbVie (ABBV) Reports Positive Clinical Trial Results on GLP-1 Weight-Loss Medications Impacting Cosmetic Satisfaction

GuruFocus64 · neutral$ABBV

FF EAI Robotics Ecosystem Inc. (FFR) and Faraday Future Announce FF OmniMind and Its Model Achieve No. 1 in RoboColiseum Embodied AI Model Ranking; Advance Sales with Several Leading U.S. Integrators of Security and Inspection Robotics Solutions

PR Newswire64 · neutral$FFR $FFAI

AbbVie reports improved facial satisfaction among weight-loss drug users

Seeking Alpha58 · neutral$ABBV

Immutep (IMMP) Reports Positive Phase I Data for IMP761 at ACR Convergence 2026

GuruFocus64 · neutral$IMMP

Spiking Joins IBM Z Day 2026 Asia Pacific Special Edition Track as a Friend of the IBM Z Community

Business Insider56 · neutral$IBM

Club Offers for Travel Enthusiasts in the U.S.

StockTitan56 · neutral$TZOO

LG ELECTRONICS EARNS FIRST ASIL D PRODUCT CERTIFICATION FOR AUTOMOTIVE CENTRAL GATEWAY SYSTEM

PR Newswire56 · neutral

SpaceX's Starlink Could Build a Nationwide Cell Network. Here's What Investors Need to Know

The Motley Fool63 · neutral$SPCX

Amazon's Ambitious Plans for Home Robotics Development

GuruFocus63 · neutral$AMZN

Timing Affects Speed, Not Total Exposure

PR Newswire50 · neutral

Microsoft's Oracle move raises new question for investors

The Street58 · neutral$MSFT $ORCL

Faraday Future and FFR Announce FF OmniMind and Its Model Achieves No. 1 in RoboColiseum Embodied AI Model Ranking; Advances Sales with Several Leading U.S. Integrators of Security and Inspection Robotics Solutions

StockTitan63 · neutral$FFAI

Immutep announces data from its Phase I study of IMP761

The Fly58 · neutral$IMMP

Innovent Announces Phase 3 CREDIT-5 Study Met Primary Endpoint, SINTBILO® (Tafolecimab Injection) as First-line Monotherapy Treatment for Hyperlipidemia Demonstrated Potent Lipid-lowering Efficacy

PR Newswire64 · neutral

Vir Biotechnology (VIR) Reports Positive Phase 3 Results for Hepatitis Delta Therapy

GuruFocus78 · bullish$VIR

Starlink Deal Adds Yet Another Growth Engine for Qualcomm Stock

Barchart67 · bullish$QCOM

Vir Biotechnology reports positive hepatitis results, early signs of possible cure

Seeking Alpha74 · bullish$VIR

Mountain Dew offers an exclusive holiday gift soda only at Walmart

The Street56 · neutral$WMT $PEP

Veradermics to Hold Conference Call to Discuss 12-Month Long-Term Results from Phase 3 ‘302’ Clinical Trial of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss

StockTitan52 · neutral$MANE

Vir Biotechnology (VIR) Reports Positive Phase 3 Eclipse 1 Trial Results for Chronic Hepatitis Delta Treatment

GuruFocus74 · bullish$VIR

Johnson & Johnson's Experimental Immunotherapy Shows Promise in Prostate Cancer; Ticker JNJ Update

GuruFocus64 · neutral$JNJ

Vir Biotechnology (VIR) Reports Promising Phase 2 Results for Chronic Hepatitis Delta Treatment

GuruFocus67 · bullish$VIR

Mineralys Therapeutics (MLYS) Reports Promising Long-Term Data on Lorundrostat for Resistant Hypertension

GuruFocus64 · neutral$MLYS

Novartis (NVS) Halts Development of Pelacarsen After Trial Shows No Efficacy

GuruFocus34 · bearish$NVS

Novartis to discontinue development of pelacarsen, Bloomberg says

The Fly38 · neutral$NVS

DeepSeek Harness Surpasses 1.5 Million Daily Users, Showcasing Rapid Adoption of Anthropic PBC's Platform (ANT)

GuruFocus64 · neutral$ANT

CoreWeave (CRWV) Seeks Partnership with Texas Governor-elect Gina Hinojosa on Data Center Expansion

GuruFocus63 · neutral$CRWV

J&J prostate cancer combination lowers PSA in small early study

Seeking Alpha63 · neutral$JNJ

Product/PR — news category tracker

Recent Product/PR stories